James Matthew Gould to Present at the October 21st Meeting of the Philadelphia Intellectual Property Law Association
Philadelphia, PA | October 2020 – RatnerPrestia’s James Matthew Gould will be speaking on “Recent Trends in ANDA Pharmaceutical Patent Litigation” at a virtual CLE meeting of the Philadelphia Intellectual Property Law Association on Wednesday, October 21, 2020 at 5:30 pm. The topic will focus on the recent Federal Circuit opinion in GlaxoSmithKline v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. Oct. 2, 2020). For more details click here: https://www.pipla.org/pipla-meeting-october-21-2020/.
RatnerPrestia is a law firm expert in all things IP. The Firm handles procurement, enforcement, licensing, commercialization, global strategic IP planning, and all related business aspects of IP. The Firm has attorneys experienced and successful in all relevant U.S. and German jurisdictions, including the U.S. Patent and Trademark Office, The German Patent Office, The European Patent Office, The U.S. International Trade Commission, and Federal Courts, both trial and appellate. This expertise extends to all areas of IP protection, including patent, design, copyright, software, trademark, and trade secret protection.